Range
4.58 - 4.89
Vol / Avg.
835.4K/811.5K
Div / Yield
-
52 Wk
3.16 - 9.06
Mkt Cap
319.5M
Payout Ratio
-
Open
4.87
P/E
-
EPS
-0.23
Shares
69M
Outstanding
69M
Total Float
58.4M
Sector: Health Care.Industry: Pharmaceuticals
CymaBay Therapeutics Inc is a part of the healthcare sector based in the United States. Its main business involves the development of therapeutics such as Arhalofenate, MBX-8025, and MBX-2982. These drugs are intended to treat serious metabolic disorders. Arhalofenate is used to treat gout, MBX-2982 is an oral, G-protein coupled receptor agonist being evaluated as a therapeutic agent for patients with Type 2 diabetes and MBX-8025 is a selective agonist for the peroxisome proliferator-activated receptor delta.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.240-0.250 -0.0100
REV0
Q4 2020Est.ActualSurprise
EPS-0.200-0.230 -0.0300
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CBAYCymaBay Therapeutics-5.89%319.5M

CymaBay Therapeutics Frequently Asked Questions

Q

How do I buy CymaBay Therapeutics (CBAY) stock?

A

You can purchase shares of CymaBay Therapeutics (NASDAQ: CBAY) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are CymaBay Therapeutics's (CBAY) competitors?

Q

What is the target price for CymaBay Therapeutics (CBAY) stock?

A

The latest price target for CymaBay Therapeutics (NASDAQ: CBAY) was reported by JonesTrading on June 14, 2021. The analyst firm set a price target for 8.00 expecting CBAY to rise to within 12 months (a possible 72.79% upside). 7 analyst firms have reported ratings in the last year.

Q

Current Stock Price for CymaBay Therapeutics (CBAY)?

A

The stock price for CymaBay Therapeutics (NASDAQ: CBAY) is $4.63 last updated Fri Jun 18 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does CymaBay Therapeutics (CBAY) pay a dividend?

A

There are no upcoming dividends for CymaBay Therapeutics.

Q

When is CymaBay Therapeutics (NASDAQ:CBAY) reporting earnings?

A
CymaBay Therapeutics’s Q2 earnings are confirmed for after-market on August 9, 2021.
Q

Is CymaBay Therapeutics (CBAY) going to split?

A

There is no upcoming split for CymaBay Therapeutics.

Q

What sector and industry does CymaBay Therapeutics (CBAY) operate in?

A

CymaBay Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.